SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Volquardsen who wrote (417)8/16/1997 8:04:00 PM
From: John Zwiener   of 1115
 
When Lidak had their phase 3 disaster last year, the company really loosened up on their info. and went into great detail on what happened. When I was talking to them then, they answered questions and backed them up. Maybe they felt a duty to explain what happened. At least the explanations were enough to get me to accumaulate an interesting position in the stock.

Now they have clammed up again. This is the usual mode for Lidak. This is how they were before, when things were going for them. Now I guess things are going for them again.

Why would BMS want to hold back the reduction in healing time? CEO Katz said that it was a c;ompetitive thing. Yamanuchi also requested the same thing, and also has held back the numbers on their European study. So I guess it is at least consistent.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext